Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVAX    crawled date : 2021 - 06 - 30    save search
Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine
Published: 2021-06-30 (Crawled : 22:00) - prnewswire.com
NVAX | $4.06 -1.46% 1.1M twitter stocktwits trandingview |
Health Technology
 | | O: 1.27% H: 0.47% C: 0.35%
covid results vaccine phase 3 trial
Gainers vs Losers
51% 49%

Top 10 Gainers
WISA 4 | $7.86 349.14% 120M twitter stocktwits trandingview |
Electronic Technology
TPET | $0.4951 114.24% 29M twitter stocktwits trandingview |
n/a
PRSO | $1.99 56.69% 52M twitter stocktwits trandingview |
Manufacturing
PALI | $6.5 56.25% 22M twitter stocktwits trandingview |
Manufacturing
JAGX | $0.1767 48.74% 430M twitter stocktwits trandingview |
Health Technology
SXTC | $2.03 45.0% 27M twitter stocktwits trandingview |
Health Technology
DYNT | $0.5255 41.87% 18M twitter stocktwits trandingview |
Health Technology
SPCB | $0.3888 40.87% 27M twitter stocktwits trandingview |
Electronic Technology
SNGX | $0.54 39.86% 7.3M twitter stocktwits trandingview |
Health Technology
MCBC | $13.795 38.92% 820K twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.